Fecal transplants may improve response to cancer immunotherapy

Date:

Share this article:

Del denne artikel:

Researchers are testing whether fecal microbiota transplants can reduce side effects and boost cancer treatment response.

For many people facing cancer, the hardest part is not only the diagnosis but what treatment does to everyday life.

Fatigue, pain and gut problems can quietly become the real battle. Researchers are now exploring an unexpected way to make that fight easier, and possibly more effective.

The work brings together microbiome science and cancer care, hinting that what happens in the gut may shape how well modern therapies work.

A gut-level shift

Scientists in Canada have reported that fecal microbiota transplants, delivered as capsules, may significantly change how patients respond to immunotherapy.

Also read: Doctor explains what you should do if you are alone and start choking

According to studies published in Nature Medicine, the approach focuses on restoring healthy gut bacteria rather than adding new drugs.

One early-stage trial in kidney cancer tested whether the capsules could be safely combined with immunotherapy.

Researchers found that adjusting the gut microbiome appeared to reduce severe digestive side effects that often force patients to stop treatment early.

Stronger responses

Separate Phase II studies looked at people with lung cancer and melanoma. After receiving the microbiota capsules, far more patients responded to immunotherapy than is usually expected with the drugs alone.

Also read: What nutrition experts say about Donald Trump’s eating habits

The trials involved small groups, but the response rates were high enough to prompt larger, Canada-wide studies now underway.

From lab to clinic

The capsules, known as LND101, were developed in London, Ontario, using material from healthy donors. Researchers say this allows production to scale if future trials confirm the benefits.

Dr. Michael Silverman of Lawson Research Institute said: "To use FMT to reduce drug toxicity and improve patients' quality of life while possibly enhancing their clinical response to cancer treatment is tremendous, and it had never been done in treating kidney cancer before this."

The research builds on earlier work in melanoma and extends a treatment already used for severe gut infections into cancer care.

Also read: Eye doctors warn common contact lens habits can damage vision

Sources: News Medical and Nature

Also read: Understanding why menthol feels cold

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

Scientists find a hidden immune pathway that could open new treatments for the deadliest lung cancer

The deadliest lung cancer has slipped past the body's defenses for decades, and researchers now think they have found a way in.

How eating dark chocolate every day may affect your heart, blood pressure and brain

A daily square after dinner feels like a guilty pleasure, but the research behind that small habit tells a more interesting story.

How eating oats every day could quietly lower your LDL cholesterol

A small daily amount of one everyday grain carries a rare regulator's stamp of approval, and newer trials keep backing it up.

The five-letter home check that catches most melanomas, and where AI now helps

Mole-mapping tools are moving into clinics, but what you notice in your own mirror is still the earliest warning.

Scientists find a hidden immune pathway that could open new treatments for the deadliest lung cancer

The deadliest lung cancer has slipped past the body's defenses for decades, and researchers now think they have found a way in.

How eating dark chocolate every day may affect your heart, blood pressure and brain

A daily square after dinner feels like a guilty pleasure, but the research behind that small habit tells a more interesting story.

How eating oats every day could quietly lower your LDL cholesterol

A small daily amount of one everyday grain carries a rare regulator's stamp of approval, and newer trials keep backing it up.